Anthony Orlando, PhD, Vice President Global Data Division

Dr. Orlando oversees Pharm-Olam's data management and biostatistics services. He brings an exceptional background in data management and biostatistics with over 30 years of experience which includes roles in pharmaceutical companies, the National Center for Toxicological Research/FDA, and CROs.

Dr. Orlando holds a Ph.D. in Biometry from Yale University School of Medicine, and has co-authored many papers in his area of expertise and has supported multiple drug NDAs for a variety of indications. Dr. Orlando's area of expertise is in the area of Mixture Analysis and Statistics, with applications in Clinical trials Phase I-Phase IV.

Dr. Orlando's heads a team of statisticians who, hold advanced degrees and are experienced in regulatory submissions, are trained to follow a rigorous, step-by-step analytical flowchart process to determine the most appropriate and powerful statistic for the set of data under study. We call this process Assumption Driven Data Analysis (ADIDA).